Non-steroidal and silent antiandrogen. Binds to androgen receptors and also inhibits androgen biosynthesis in vitro. In rats in vivo it inhibits androgen-induced prostate weight increase and inhibits negative androgen-dependent gonadotropin feedback leading to an increase in luteinising hormone and testosterone. Orally active.
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
|ethanol||7.93||25 with gentle warming|
Preparing Stock Solutions
The following data is based on the product molecular weight 317.22. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.25 mM||12.61 mL||63.05 mL||126.1 mL|
|1.25 mM||2.52 mL||12.61 mL||25.22 mL|
|2.5 mM||1.26 mL||6.3 mL||12.61 mL|
|12.5 mM||0.25 mL||1.26 mL||2.52 mL|
References are publications that support the biological activity of the product.
Ayub and Levell (1987) Inhibition of rat testicular 17-α-hydroxylase and 17,20-lyase activities by anti-androgens (flutamide, hydroxyflutamide, RU23908, cyproterone acetate) in vitro. J.Steroid Biochem. 28 43 PMID: 2956461
Raynaud et al (1979) Action of a non-steroid anti-androgen, RU 23908, in peripheral and central tissues. J.Steroid Biochem. 11 93 PMID: 385986
Raynaud et al (1984) The pure antiandrogen RU 23908 (Anandron), a candidate of choice for the combined antihormonal treatment of prostatic cancer. The Prostate 5 299 PMID: 6374639
Raynaud et al (1985) Pharmacology and clinical studies with RU 23908 (Anandron). Prog.Clin.Biol.Res. 185A 99 PMID: 4034583
If you know of a relevant reference for Nilutamide, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Nilutamide, Nilutamide supplier, Androgen, receptor, antagonists, Orally, active, Dihydrotestosterone, Receptors, RU23908, chemotherapeutics, RU, 23908, Receptor, 1759, Tocris Bioscience
Citations for Nilutamide
Citations are publications that use Tocris products.
Currently there are no citations for Nilutamide. Do you know of a great paper that uses Nilutamide from Tocris? Please let us know.
Reviews for Nilutamide
There are currently no reviews for this product. Be the first to review Nilutamide and earn rewards!
Have you used Nilutamide?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.